{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:35:52Z","timestamp":1790908552074,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"MIUR-Italy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad of Spain","doi-asserted-by":"publisher","award":["CTQ2016-77270-R"],"award-info":[{"award-number":["CTQ2016-77270-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007364","name":"Fondazione CR Firenze","doi-asserted-by":"publisher","award":["2016\/0845"],"award-info":[{"award-number":["2016\/0845"]}],"id":[{"id":"10.13039\/100007364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bioorg.2019.03.053","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T12:08:14Z","timestamp":1553256494000},"page":"534-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Dual targeting of PTP1B and glucosidases with new bifunctional iminosugar inhibitors to address type 2 diabetes"],"prefix":"10.1016","volume":"87","author":[{"given":"Xhenti","family":"Ferhati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Matassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giulia","family":"Fabbrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Goti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Morrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio J.","family":"Moreno-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Paoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.03.053_b0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bioorg.2019.03.053_b0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1139\/bcb-2014-0152","article-title":"Children have type 2 diabetes too: an historical perspective","volume":"93","author":"Dean","year":"2015","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.bioorg.2019.03.053_b0015","first-page":"15","article-title":"The role of the pharmacist in the management of type 2 diabetes: current insights and future directions","volume":"6","author":"Hughes","year":"2017","journal-title":"Integr. Pharm. Res. Pract"},{"issue":"7580","key":"10.1016\/j.bioorg.2019.03.053_b0020","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.39022.462546.80","article-title":"Management of hyperglycaemia in type 2 diabetes: the end of recurrent failure?","volume":"333","author":"Heine","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.bioorg.2019.03.053_b0025","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1126\/science.283.5407.1544","article-title":"Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene","volume":"283","author":"Elchebly","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2019.03.053_b0030","doi-asserted-by":"crossref","first-page":"E368","DOI":"10.3390\/md15120368","article-title":"\u03b1-Glucosidase and protein tyrosine phosphatase 1B inhibitory activity of plastoquinones from marine brown alga Sargassum serratifolium","volume":"15","author":"Ali","year":"2017","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bioorg.2019.03.053_b0035","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jep.2016.10.007","article-title":"Protein tyrosine phosphatase 1B and \u03b1-glucosidase inhibitory activities of Pueraria lobata root and its constituents","volume":"194","author":"Seong","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2019.03.053_b0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cbi.2016.04.020","article-title":"Coumarins from Angelica decursiva inhibit \u03b1-glucosidase activity and protein tyrosine phosphatase 1B","volume":"252","author":"Ali","year":"2016","journal-title":"Chem.-Biol. Interact."},{"key":"10.1016\/j.bioorg.2019.03.053_b0045","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.3390\/molecules22010028","article-title":"Promising inhibitory effects of anthraquinones, naphthopyrone, and naphthalene glycosides, from Cassia obtusifolia on \u03b1-glucosidase and human protein tyrosine phosphatases 1B","volume":"22","author":"Jung","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.03.053_b0050","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/acs.jnatprod.5b01128","article-title":"Identification of PTP1B and \u03b1-glucosidase inhibitory serrulatanes from Eremophila spp. by combined use of dual high-resolution PTP1B and \u03b1-glucosidase inhibition profiling and HPLC-HRMS-SPE-NMR","volume":"79","author":"Wubshet","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2019.03.053_b0055","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1080\/14756366.2017.1368502","article-title":"Inhibition of protein tyrosine phosphatase (PTP1B) and \u03b1-glucosidase by geranylated flavonoids from Paulownia tomentosa","volume":"32","author":"Song","year":"2017","journal-title":"J. Enz. Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.phytochem.2018.08.001","article-title":"Chalcone derivatives from the root bark of Morus alba L. act as inhibitors of PTP1B and \u03b1-glucosidase","volume":"155","author":"Ha","year":"2018","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bioorg.2019.03.053_b0065","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.bioorg.2019.03.053_b0070","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1210\/jc.2007-1702","article-title":"Type 1 Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance","volume":"93","author":"Langeveld","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bioorg.2019.03.053_b0075","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.bcmd.2007.09.002","article-title":"Overweight, insulin resistance and type II diabetes in type I Gaucher disease patients in relation to enzyme replacement therapy","volume":"40","author":"Langeveld","year":"2008","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bioorg.2019.03.053_b0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ymgme.2008.10.001","article-title":"A crosssectional, mono-centric pilot study of insulin resistance in enzyme replacement therapy patients with Gaucher type 1 without overweight","volume":"96","author":"Ucar","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bioorg.2019.03.053_b0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bcmd.2016.10.012","article-title":"Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease","volume":"68","author":"Nascimbeni","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bioorg.2019.03.053_b0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1476-511X-9-113","article-title":"Sphingolipids: the nexus between Gaucher disease and insulin resistance","volume":"9","author":"Fuller","year":"2010","journal-title":"Lip. Health Dis."},{"key":"10.1016\/j.bioorg.2019.03.053_b0095","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1021\/jm301557k","article-title":"Pharmacological chaperones as therapeutics for lysosomal storage diseases","volume":"56","author":"Boyd","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0100","doi-asserted-by":"crossref","first-page":"5497","DOI":"10.1039\/C6CC01564F","article-title":"Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases","volume":"52","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2019.03.053_b0105","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.bmc.2009.03.042","article-title":"Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity","volume":"17","author":"Navarrete-Vazquez","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0110","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/cmdc.201200197","article-title":"Synthesis, structure-activity relationship and docking studies of substituted aryl thiazolyl phenylsulfonamides as potential protein tyrosine phosphatase 1B inhibitors","volume":"7","author":"Varshney","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2019.03.053_b0115","series-title":"Iminosugars: from Synthesis to Therapeutic Applications","year":"2007"},{"key":"10.1016\/j.bioorg.2019.03.053_b0120","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1021\/np010360f","article-title":"New sugar-mimic alkaloids from the pods of Angylocalyx pynaertii","volume":"65","author":"Yasuda","year":"2002","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2019.03.053_b0125","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2337\/db06-1619","article-title":"Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity","volume":"56","author":"Aerts","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.bioorg.2019.03.053_b0130","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/chem.200801578","article-title":"Total syntheses of Casuarine and its 6-O-\u03b1-Glucoside: complementary inhibition towards glycoside hydrolases of the GH31 and GH37 families","volume":"15","author":"Cardona","year":"2009","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bioorg.2019.03.053_b0135","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2165\/00003495-200059030-00012","article-title":"Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus","volume":"59","author":"Scott","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2019.03.053_b0140","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/cbic.201500292","article-title":"Human acid \u03b2-glucosidase inhibition by carbohydrate derived iminosugars: towards new pharmacological chaperones for Gaucher disease","volume":"16","author":"Parmeggiani","year":"2015","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bioorg.2019.03.053_b0145","doi-asserted-by":"crossref","first-page":"64847","DOI":"10.1039\/C6RA15806D","article-title":"Evidence for a multivalent effect in inhibition of sulfatases involved in lysosomal storage disorders (LSDs)","volume":"6","author":"D\u2019Adamio","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2019.03.053_b0150","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/07328300008544101","article-title":"Polyhydroxypyrrolidine glycosidase inhibitors related to (+)-lentiginosine","volume":"19","author":"Cardona","year":"2000","journal-title":"J. Carbohydr. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0155","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/0957-4166(96)00200-5","article-title":"(1S,2S,7R,8aS)- and (1S,2S,7S,8aS)-Trihydroxyoctahydroindolizine: two new glycosidase inhibitors by nitrone cycloaddition strategy","volume":"7","author":"Goti","year":"1996","journal-title":"Tetrahedron: asymmetry"},{"key":"10.1016\/j.bioorg.2019.03.053_b0160","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1002\/ejoc.201200587","article-title":"Double reductive amination and selective Strecker reaction of a d-Lyxaric aldehyde: synthesis of diversely functionalized 3,4,5-trihydroxypiperidines","author":"Matassini","year":"2012","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0165","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1002\/ejoc.201402427","article-title":"Polyhydroxyamino-piperidine-type iminosugars and pipecolic acid analogues from a d-mannose-derived aldehyde","author":"Matassini","year":"2014","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0170","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/ejoc.201000632","article-title":"Synthesis biological evaluation and docking studies of casuarine analogs: effects of structural modifications at ring B on inhibitory activity towards glucoamylase","author":"Bonaccini","year":"2010","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0175","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1039\/b926600c","article-title":"Casuarine-6-O-\u03b1-d-glucoside and its analogues are tight binding inhibitors of insect and bacterial trehalases","volume":"46","author":"Cardona","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2019.03.053_b0180","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1002\/ejoc.201101096","article-title":"Total synthesis of (+)-hyacinthacine A1, (+)-7a-epi-hyacinthacine A1, 6(R)\u20136-hydroxyhyacinthacine A1 and 6(S)-6-hydroxy-7a-epi-hyacinthacine A1","author":"D\u2019Adamio","year":"2011","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0185","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1039\/C4OB01117A","article-title":"6-Azido hyacinthacine A2 gives a straightforward access to the first multivalent pyrrolizidine architectures","volume":"12","author":"D\u2019Adamio","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0190","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1039\/C4OB02016B","article-title":"New synthesis and biological evaluation of uniflorine A derivatives: towards specific insect trehalase inhibitors","volume":"13","author":"D\u2019Adamio","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0195","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1002\/ejoc.201300103","article-title":"Synthesis and glycosidase inhibition studies of 5-methyl-Substituted tetrahydroxyindolizidines and -pyrrolizidines related to natural hyacinthacines B","author":"Martella","year":"2013","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0200","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/ejoc.201501427","article-title":"Cycloadditions of sugar-derived nitrone targeting polyhydroxylated indolizidines","author":"Martella","year":"2016","journal-title":"Eur. J. Org. Chem."},{"issue":"27","key":"10.1016\/j.bioorg.2019.03.053_b0205","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1002\/anie.200900488","article-title":"Iterative in situ click chemistry creates antibody-like protein-capture agents","volume":"48","author":"Agnew","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2019.03.053_b0210","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1021\/cr0783479","article-title":"Cu-catalyzed azide\u2212alkyne cycloaddition","volume":"108","author":"Meldal","year":"2008","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2019.03.053_b0215","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1021\/ol8007759","article-title":"Novel polyhydroxylated cyclic nitrones and N-Hydroxypyrrolidines through BCl3-mediated deprotection","volume":"10","author":"Desvergnes","year":"2008","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2019.03.053_b0220","series-title":"Synthetic Multivalent Molecules: Concepts and Biomedical Applications","year":"2004"},{"issue":"15","key":"10.1016\/j.bioorg.2019.03.053_b0225","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1002\/anie.200502794","article-title":"Synthetic multivalent ligands as probes of signal transduction","volume":"45","author":"Kiessling","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"issue":"25","key":"10.1016\/j.bioorg.2019.03.053_b0230","doi-asserted-by":"crossref","first-page":"7490","DOI":"10.1002\/chem.200800700","article-title":"Glycomimetics and glycodendrimers as high affinity microbial anti-adhesins","volume":"14","author":"Imberty","year":"2008","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bioorg.2019.03.053_b0235","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1039\/C0OB00389A","article-title":"Insights in the rational design of synthetic multivalent glycoconjugates as lectin ligands","volume":"9","author":"Deniaud","year":"2011","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0240","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1039\/c2cs35424a","article-title":"Cyclodextrin-based multivalent glycodisplays: covalent and supramolecular conjugates to assess carbohydrate\u2013protein interactions","volume":"42","author":"Martinez","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioorg.2019.03.053_b0245","doi-asserted-by":"crossref","first-page":"11616","DOI":"10.1002\/chem.201402537","article-title":"Multivalent inhibitors for carbohydrate-processing enzymes: beyond the \u201cLock-and-Key\u201d concept","volume":"20","author":"Gouin","year":"2014","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bioorg.2019.03.053_b0250","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/cbic.201402026","article-title":"The multivalent effect in glycosidase inhibition: a new, rapidly emerging topic in glycoscience","volume":"15","author":"Compain","year":"2014","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bioorg.2019.03.053_b0255","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1039\/C5NJ00462D","article-title":"Synthesis and biological properties of multivalent iminosugars","volume":"39","author":"Zelli","year":"2015","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0260","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1039\/C5OB01405K","article-title":"Emerging trends in enzyme inhibition by multivalent nanoconstructs","volume":"13","author":"Kanfar","year":"2015","journal-title":"Org. Biomol. Chem."},{"issue":"49","key":"10.1016\/j.bioorg.2019.03.053_b0265","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1016\/j.tetlet.2016.10.080","article-title":"Are enzymes sensitive to the multivalent effect? Emerging evidence with glycosidases","volume":"57","author":"Matassini","year":"2016","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2019.03.053_b0270","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1021\/jo8008935","article-title":"Expeditive synthesis of glycodendrimer scaffolds based on versatile TRIS and mannoside derivatives","volume":"73","author":"Chabre","year":"2008","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0275","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1039\/b616751a","article-title":"1,2,3-Triazoles as peptide bond isosteres: synthesis and biological evaluation of cyclotetrapeptide mimics","volume":"5","author":"Bock","year":"2007","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0280","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1517\/17460441.2012.682725","article-title":"The impact of click chemistry in medicinal chemistry","volume":"7","author":"Hou","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"issue":"8","key":"10.1016\/j.bioorg.2019.03.053_b0285","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1039\/C5NJ01372K","article-title":"Catalyst-free amidation of aldehyde with amine under mild conditions","volume":"39","author":"Yang","year":"2015","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0290","doi-asserted-by":"crossref","first-page":"899","DOI":"10.5114\/aoms.2012.31621","article-title":"\u03b1-Glucosidase inhibitors and their use in clinical practice","volume":"8","author":"Derosa","year":"2012","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.bioorg.2019.03.053_b0295","doi-asserted-by":"crossref","first-page":"13507","DOI":"10.1016\/S0021-9258(18)92727-4","article-title":"Human lysosomal \u03b1-glucosidase","volume":"266","author":"Hermans","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2019.03.053_b0300","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0006-291X(91)91906-S","article-title":"Identification of a point mutation in the human lysosomal \u03b1-glucosidase gene causing infantile glycogenosis type II","volume":"179","author":"Hermans","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.bioorg.2019.03.053_b0305","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.bioorg.2019.03.053_b0310","doi-asserted-by":"crossref","first-page":"36608","DOI":"10.1074\/jbc.M406499200","article-title":"Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt\/protein kinase B","volume":"279","author":"Stratford","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0315","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.1016\/j.tet.2007.02.087","article-title":"A versatile approach to pyrrolidine azasugars and homoazasugars based on a highly diastereoselective reductive benzyloxymethylation of protected tartarimide","volume":"63","author":"Zhou","year":"2007","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2019.03.053_b0320","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/molecules23020436","article-title":"Probing the influence of linker length and flexibility in the design and synthesis of new trehalase inhibitors","volume":"23","author":"D\u2019Adamio","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.03.053_b0325","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1016\/j.bmc.2013.06.054","article-title":"Rapid modifications of N-substitution in iminosugars: Development of new \u03b2-glucocerebrosidase inhibitors and pharmacological chaperones for Gaucher disease","volume":"21","author":"Cheng","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0330","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/jo101955q","article-title":"Synthesis and isolation of 5,6-dihydro-4H-1,3-oxazine hydrobromides by autocyclization of N-(3-Bromopropyl)amides","volume":"76","author":"Reddy","year":"2011","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0335","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2217\/rme.09.44","article-title":"Ficoll-Paque versus Lymphoprep: a comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparations","volume":"4","author":"Yeo","year":"2009","journal-title":"Regen. Med."},{"key":"10.1016\/j.bioorg.2019.03.053_b0340","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejmech.2013.11.001","article-title":"Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells","volume":"71","author":"Ottan\u00e0","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0345","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/clinchem\/28.4.569","article-title":"Beta-glucosidase assays in the diagnosis of Gaucher's disease","volume":"28","author":"Daniels","year":"1982","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bioorg.2019.03.053_b0350","first-page":"62","article-title":"Beta-glucosidase activity in fibroblasts from homozygotes and heterozygotes for Gaucher's disease","volume":"23","author":"Beutler","year":"1971","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bioorg.2019.03.053_b0355","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1399-0004.1978.tb04242.x","article-title":"Synthetic substrate beta-glucosidase activity in leukocytes: a reproducible method for the identification of patients and carriers of Gaucher's disease","volume":"13","author":"Wenger","year":"1978","journal-title":"Clin. Genet."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819300707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819300707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:52:13Z","timestamp":1758613933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819300707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":71,"alternative-id":["S0045206819300707"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.03.053","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual targeting of PTP1B and glucosidases with new bifunctional iminosugar inhibitors to address type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.03.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}